ANXA2 is Correlated With the Molecular Features and Clinical Prognosis of Glioma, and Acts as a Potential Marker of ImmunosuppressionKaiming Ma, Jun Yang, Suhua Chen et al.|Research Square|2021Cited by 0
PDIA4 correlates with poor prognosis and is a potential biomarker in gliomaHaoyu Li, Jun Su, Qing Liu et al.|Research Square|2020Cited by 0